Reason for the recent volumeI have been trying to figure out the reason for the recent volume in this company, and have bought more shares because that is one of the patterns I look for. I was thinking more news is imminent and putting on a larger position during higher volume makes sense. Well this might be it, "
Taylor refreshes Diagnos buy".
Taylor refreshes Diagnos buy
Diagnos Inc (2)(C:ADK)
Shares Issued 52,280,010
Last Close7/9/2010
.35
Friday July 09 2010 - In the News
JayTaylor in the June 18, 2010, edition of Gold, Energy & Tech Stocksrefreshes his buy recommendation for Diagnos Inc., recently 40 cents.Mr. Taylor said buy on April 19, 2010, at 45 cents. A $1,000 investmentat 45 cents is now worth $889. Diagnos owns and develops health care,mining and music software. Its leading software is CARA(computer-assisted retinal analysis), which helps eye care professionalsdiagnose diabetic retinopathy.The company recently signed a distribution deal for its CARA softwarewith the Mafatlal Group in India. The deal could see Mafatlal processup to 5,000 patients a day using the CARA software. Diagnos willreceive $5 per patient, which would equal $25,000 per day if Mafatlaldid indeed process 5,000 patients a day. Mr. Taylor notes even ifMafatlal only processes an average of 2,000 patients a day, that wouldstill give Diagnos $10,000 per day or $2.5-million per year. Thenewsletter writer thinks Diagnos's software shows potential to become ahuge success, especially in less-developed countries like China andIndia, where sales could explode. He thinks this stock could increaseto much higher levels.
Oddly enough I feel there is something else in the wind.....why would they have also recently giving themselves a bunch of juicy options.. The ducks are all lining up in a row here and I am poised to take advantage of the situation....along with some profit....
Cheers
Please do your due diligence.